Pancreatic Cancer Research

ResearcherNantong UniversityActive in the last 2 years

Xihao Yao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9875-1117; OpenAlex author ID A5038093798. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 3 papers · 2025: none · 2026: 1 paper

Papers 7

  1. Circ-0030167/IGF2BP1 Induces Mitophagy-Mediated Ferroptosis via HMOX1 mRNA Stabilization in Pancreatic Cancer. First author DOI 10.1111/cas.70356↗
  2. Corrigendum to "Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging … Co-author DOI 10.1016/j.canlet.2023.216603↗
  3. Dual-crosslinking gelatin-hyaluronic acid methacrylate based biomimetic PDAC desmoplastic niche enhances tumor-associated macrophages recruitment and M2-like p… Co-author DOI 10.1016/j.ijbiomac.2024.131826↗
  4. Long non-coding RNA LINC00930 targeting miR-6792-3p/ZBTB16 regulates the proliferation and EMT of pancreatic cancer. Co-author DOI 10.1186/s12885-024-12365-9↗
  5. Biomimetic Microenvironmental Stiffness Boosts Stemness of Pancreatic Ductal Adenocarcinoma via Augmented Autophagy. Co-author DOI 10.1021/acsbiomaterials.3c00487↗
  6. Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and t… Co-author DOI 10.1016/j.canlet.2021.04.030↗
  7. LncRNA TP73-AS1 enhances the malignant properties of pancreatic ductal adenocarcinoma by increasing MMP14 expression through miRNA -200a sponging. Co-author DOI 10.1111/jcmm.16425↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuhua Lu · 6 shared papers, 2021–2026 · strength 1.19
  2. Yibing Guo · 6 shared papers, 2021–2024 · strength 1.07
  3. Xiaohong Li · 4 shared papers, 2021–2024 · strength 0.71
  4. Yingqing Mao · 3 shared papers, 2021–2024 · strength 0.54
  5. Qingsong Guo · 2 shared papers, 2024 · strength 0.43
  6. Di Wu · 2 shared papers, 2023–2024 · strength 0.39
  7. Tiancheng Gong · 2 shared papers, 2023–2024 · strength 0.39
  8. Jingjing Lu · 2 shared papers, 2021–2024 · strength 0.34
  9. Qiyang Chen · 1 shared paper, 2026 · strength 0.33
  10. Xiaohong Li · 1 shared paper, 2026 · strength 0.33
  11. Zhiwei Wang · 1 shared paper, 2026 · strength 0.33
  12. Qun Zhao · 1 shared paper, 2026 · strength 0.33
  13. Yuhua Lu · 1 shared paper, 2024 · strength 0.22
  14. Yao Wang · 1 shared paper, 2024 · strength 0.22
  15. Haopeng Pan · 1 shared paper, 2023 · strength 0.18
  16. Haiyan Miao · 1 shared paper, 2021 · strength 0.14
  17. Hongquan Qiu · 1 shared paper, 2021 · strength 0.14
  18. Zhiwei Wang · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.